Projected Income Statement: Philips NV

Forecast Balance Sheet: Philips NV

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 4,676 6,087 5,817 5,236 5,291 4,777 3,980 3,014
Change - 30.18% -4.44% -9.99% 1.05% -9.71% -16.68% -24.27%
Announcement Date 1/24/22 1/30/23 1/29/24 2/19/25 2/10/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Philips NV

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 729 788 554 663 660 886.3 923.8 966.7
Change - 8.09% -29.7% 19.68% -0.45% 34.29% 4.23% 4.64%
Free Cash Flow (FCF) 1 900 -961 1,582 906 512 1,445 1,695 1,854
Change - -206.78% 264.62% -42.73% -43.49% 182.24% 17.28% 9.4%
Announcement Date 1/24/22 1/30/23 1/29/24 2/19/25 2/10/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Philips NV

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 17.4% 12.93% 15.66% 16.55% 17.08% 17.26% 17.94% 18.49%
EBIT Margin (%) 11.97% 7.39% 10.57% 11.53% 12.31% 12.6% 13.34% 14.2%
EBT Margin (%) 2.97% -9.71% -2.9% 0.68% 6.63% 7.79% 9.39% 10.96%
Net margin (%) 19.35% -9.02% -2.56% -3.9% 5.02% 5.83% 7.01% 8.18%
FCF margin (%) 5.25% -5.39% 8.71% 5.03% 2.87% 8.03% 9.01% 9.43%
FCF / Net Income (%) 27.12% 59.76% -339.48% -129.06% 57.21% 137.62% 128.57% 115.34%

Profitability

        
ROA 5.1% 2.74% 3.82% -2.4% 5.39% 3.19% 4.22% 4.9%
ROE 25.32% 6.1% 9.08% 10.82% 13.12% 11.65% 12.73% 13.76%

Financial Health

        
Leverage (Debt/EBITDA) 1.57x 2.64x 2.04x 1.76x 1.74x 1.54x 1.18x 0.83x
Debt / Free cash flow 5.2x -6.33x 3.68x 5.78x 10.33x 3.31x 2.35x 1.63x

Capital Intensity

        
CAPEX / Current Assets (%) 4.25% 4.42% 3.05% 3.68% 3.7% 4.93% 4.91% 4.92%
CAPEX / EBITDA (%) 24.42% 34.19% 19.47% 22.23% 21.67% 28.54% 27.38% 26.6%
CAPEX / FCF (%) 81% -82% 35.02% 73.18% 128.91% 61.33% 54.51% 52.14%

Items per share

        
Cash flow per share 1 1.658 -0.1816 2.251 1.667 1.218 2.245 2.318 2.677
Change - -110.96% 1,339.49% -25.96% -26.94% 84.34% 3.26% 15.49%
Dividend per Share 1 0.7868 0.7868 0.8219 0.8428 - 0.8419 0.8861 0.9647
Change - 0% 4.47% 2.55% - - 5.24% 8.87%
Book Value Per Share 1 15.36 13.91 12.68 12.75 - 12.28 12.92 13.48
Change - -9.4% -8.88% 0.61% - - 5.17% 4.35%
EPS 1 3.379 -1.685 -0.4932 -0.7437 0.93 1.097 1.372 1.626
Change - -149.86% 70.73% -50.8% 225.05% 17.97% 25.08% 18.52%
Nbr of stocks (in thousands) 905,498 932,751 923,773 934,049 950,979 951,289 951,289 951,289
Announcement Date 1/24/22 1/30/23 1/29/24 2/19/25 2/10/26 - - -
1EUR
Estimates
2026 *2027 *
P/E ratio 22.5x 18x
PBR 2.01x 1.91x
EV / Sales 1.57x 1.46x
Yield 3.41% 3.59%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
24.68EUR
Average target price
27.98EUR
Spread / Average Target
+13.35%

Quarterly revenue - Rate of surprise